Henry Ji is Director of Sorrento Therapeutics, Inc.. Currently has a direct ownership of 6.27 Million shares of SRNE, which is worth approximately $2.07 Million. The most recent transaction as insider was on Dec 15, 2022, when has been sold 1,500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.27M
0% 3M change
0% 12M change
Total Value Held $2.07 Million

Henry Ji Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2022
BUY
Grant, award, or other acquisition
-
1,500,000 Added 19.32%
6,265,805 Common Stock
Sep 07 2022
BUY
Open market or private purchase
$179,554 $2.02 p/Share
88,888 Added 1.83%
4,765,805 Common Stock
Sep 06 2022
BUY
Open market or private purchase
$108,888 $1.96 p/Share
55,555 Added 1.17%
4,676,917 Common Stock
Sep 02 2022
BUY
Grant, award, or other acquisition
-
2,500,000 Added 35.11%
4,621,362 Common Stock
Aug 26 2022
BUY
Open market or private purchase
$70,333 $2.11 p/Share
33,333 Added 1.55%
2,121,362 Common Stock
Aug 25 2022
BUY
Open market or private purchase
$45,777 $2.06 p/Share
22,222 Added 1.05%
2,088,029 Common Stock
Jun 14 2022
BUY
Open market or private purchase
$14,000 $1.4 p/Share
10,000 Added 0.48%
2,065,807 Common Stock
Sep 29 2021
BUY
Exercise of conversion of derivative security
$40,000 $4.0 p/Share
10,000 Added 0.48%
2,055,807 Common Stock

Also insider at

VCKA
Vickers Vantage Corp. I Financial Services
HJ

Henry Ji

Director
San Diego, CA

Track Institutional and Insider Activities on SRNE

Follow Sorrento Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRNE shares.

Notify only if

Insider Trading

Get notified when an Sorrento Therapeutics, Inc. insider buys or sells SRNE shares.

Notify only if

News

Receive news related to Sorrento Therapeutics, Inc.

Track Activities on SRNE